1 / 4

Global Erythropoietin Drug Market Worth $14.4 Billion by 2022

Market research report with industry analysis on "Global Erythropoietin Drug Market Outlook (2016-2022)" is made available by Orbis Research.

JoyAshley
Télécharger la présentation

Global Erythropoietin Drug Market Worth $14.4 Billion by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Erythropoietin Drug Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 2022 Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

  2. Global Erythropoietin Drug Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 202 Global Erythropoietin Drug Market is accounted for $8.04 billion in 2016 and is expected to reach $14.4 billion by 2022 growing at a CAGR of 10.2% from 2016 to 2022. Rising number of chronic kidney diseases (CKD) and dialysis patient pools are the major drivers for the market. Browse the report: http://www.orbisresearch.com/reports/index/erythropoietin-drug-global-market-outlook-2016-2022 Moreover, increasing cases of cancer, HIV‘s and ESRD (End Stage Renal Diseases) are some of the factors enhancing the market growth. However, growing competition from substitute drugs and rising threats from thrombosis and PRCA are the factors inhibiting the market size.By Application, anemia segment leads the Erythropoietin Drugs market during the forecast period. On the other hand, retail pharmacies in end user segment dominated the global market with a huge market share. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

  3. Global Erythropoietin Drug Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 202 In terms of geography, Europe commanded the maximum market share and will continue to dominate the market over the forecast period. Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/249835 Some of the key players in the market include Johnson and Johnson, Hospira, Inc., F. Hoffmann-La Roche AG, Amgen Inc, Kyowa Hakko Kirin Co., Ltd, 3SBio Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Intas Pharmaceuticals, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries, JCR Pharmaceuticals, LG Life Science, Novartis AG, Shenyang Sunshine Pharmaceutical, Sihuan Pharmaceutical, Uni-Bio Science, Wanbang Biochemical Pharmaceuticals, Pfizer Inc., Chugai Pharmaceutical and Dragon Pharma. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

  4. Global Erythropoietin Drug Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 202 About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817 enquiry@orbisresearch.com sales@orbisresearch.com Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

More Related